We describe here a protocol for labelling autologous white blood cells with 111 In-oxine based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.
No takes yet. Share an insight, caveat, or question.
Roca et al. (2010) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: